# Hyper- and Hypokalemic Periodic Paralysis Study

> **NCT00494507** · PHASE3 · COMPLETED · sponsor: **University of Rochester** · enrollment: 71 (actual)

## Conditions studied

- Hyperkalemic Periodic Paralysis
- Hypokalemic Periodic Paralysis

## Interventions

- **DRUG:** Dichlorphenamide (double-blind)
- **DRUG:** Placebo (double-blind)
- **DRUG:** Dichlorphenamide (open-label)

## Key facts

- **NCT ID:** NCT00494507
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494507, "Hyper- and Hypokalemic Periodic Paralysis Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00494507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
